The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 2,001 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 6,848 | 6,987,856 | SH | SOLE | 6,987,856 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 24,405 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 18,484 | 2,577,996 | SH | SOLE | 2,577,996 | 0 | 0 | ||
| ALPHATEC HOLDINGS INC | COM NEW | 02081G201 | 2,533 | 751,756 | SH | SOLE | 751,756 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 12,071 | 4,311,103 | SH | SOLE | 4,311,103 | 0 | 0 | ||
| BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 16,685 | 285,259 | SH | SOLE | 285,259 | 0 | 0 | ||
| CATABASIS PHARMACEUTICALS IN | COM | 14875P107 | 1,733 | 2,166,154 | SH | SOLE | 2,166,154 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,887 | 656,148 | SH | SOLE | 656,148 | 0 | 0 | ||
| CANCER GENETICS INC | COM | 13739U104 | 639 | 614,411 | SH | SOLE | 614,411 | 0 | 0 | ||
| CORREVIO PHARMA CORP | COM | 22026V105 | 3,611 | 898,157 | SH | SOLE | 898,157 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 6,957 | 1,218,401 | SH | SOLE | 1,218,401 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM NEW | 12648L601 | 11,452 | 5,302,063 | SH | SOLE | 5,302,063 | 0 | 0 | ||
| DOVA PHARMACEUTICALS INC | COM | 25985T102 | 145 | 6,900 | SH | SOLE | 6,900 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 3,158 | 551,078 | SH | SOLE | 551,078 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 2,705 | 535,590 | SH | SOLE | 535,590 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,053 | 138,100 | SH | SOLE | 138,100 | 0 | 0 | ||
| MELINTA THERAPEUTICS INC | COM | 58549G100 | 7,736 | 1,958,595 | SH | SOLE | 1,958,595 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 2,039 | 378,295 | SH | SOLE | 378,295 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 1,105 | 227,919 | SH | SOLE | 227,919 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 5,118 | 1,728,887 | SH | SOLE | 1,728,887 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 5,486 | 2,324,782 | SH | SOLE | 2,324,782 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 3,320 | 185,887 | SH | SOLE | 185,887 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 3,666 | 225,877 | SH | SOLE | 225,877 | 0 | 0 | ||
| SPRING BANK PHARMACEUTICALS | COM | 849431101 | 856 | 71,050 | SH | SOLE | 71,050 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 539 | 448,777 | SH | SOLE | 448,777 | 0 | 0 | ||
| SPERO THERAPEUTICS INC | COM | 84833T103 | 2,380 | 226,444 | SH | SOLE | 226,444 | 0 | 0 | ||
| SENSUS HEALTHCARE INC | COM | 81728J109 | 317 | 37,858 | SH | SOLE | 37,858 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 10,317 | 3,849,711 | SH | SOLE | 3,849,711 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 7,450 | 324,600 | SH | SOLE | 324,600 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,320 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||